报价延迟最少15分钟:2026/04/25 15:39 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.32 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-1.27/-1.16
|
|
企业价值
114.77M
|
| 资产负债 |
|
每股账面净值
1.83
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
7.95M
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs. |
